Mai Capital Management Maia Biotechnology, Inc. Transaction History
Mai Capital Management
- $13.2 Billion
- Q4 2024
A detailed history of Mai Capital Management transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Mai Capital Management holds 675 shares of MAIA stock, worth $1,269. This represents 0.0% of its overall portfolio holdings.
Number of Shares
675Holding current value
$1,269% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MAIA
# of Institutions
19Shares Held
1.38MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA583KShares$1.1 Million0.0% of portfolio
-
Halter Ferguson Financial Inc. Carmel, IN241KShares$452,7370.2% of portfolio
-
Geode Capital Management, LLC Boston, MA198KShares$371,3450.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$147,6190.0% of portfolio
-
Centric Wealth Management68.2KShares$128,2510.04% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $20.6M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...